Skip to main content

Data Explorer

Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.

Recall totals

All FDA and USDA recalls in Public Health Trace, June 2012 to September 2026.

37,135
Total recall recordsAll FDA and USDA recalls in Public Health Trace
9,799
Class I recallsReasonable probability of serious health consequences
24,349
Class II recallsTemporary or medically reversible health consequences
2,891
Class III recallsNot likely to cause adverse health consequences

Quick insights

A snapshot of the most notable patterns across all recorded FDA and USDA recalls.

Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap. 53 recalls
Most common hazardLack of Assurance of Sterility 2,072 recalls
Most affected stateHawaii 200 recalls mention this state

Download matching recalls as CSV

CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.

Filters
Recall details
Location
Date range
Sort results
Clear filters
Metric
View
Recalls announced by month (Year to date)

A chart of recalls grouped by month.

Download CSV

Source: FDA and USDA public dataLast updated

Summary (Year to date)

  • 1,527 recalls have been announced year to date.
  • Aug 2026 was 24% lower than the previous complete period (Jul 2026: 240).
  • The highest complete period was Jun 2026 (297).
  • Sep 2026 is incomplete and not included in the figures above.
  • Complete data
  • Incomplete
Recalls by class

A bar chart of the total number of recalls in this dataset by recall class.

Recalls by class
ClassRecalls
Class II24,349
Class I9,799
Class III2,891
Not Yet Classified1
Download CSV
Recalls by class
ClassRecalls
Class II24,349
Class I9,799
Class III2,891
Not Yet Classified1

Showing 11,241–11,260 of 17,237 recalls

FDA Recall Terminated Historical recordClass II

Lidocaine all strengths, all dosage forms and all packaging, Rx Only, Avella of Houston, Houston, TX 77054

by Advanced Pharma Inc.

Reason
Labeling: Not Elsewhere Classified: Products may contain synthetic latex and/or natural latex.
Published
May 31, 2017
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Ropivacaine HCl in 0.9% Sodium Chloride all strengths, all dosage forms and all packaging, Rx Only, Avella of Houston, Houston, TX 77054

by Advanced Pharma Inc.

Reason
Labeling: Not Elsewhere Classified: Products may contain synthetic latex and/or natural latex.
Published
May 31, 2017
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Bupivacaine HCl in 0.9% Sodium Chloride all strengths, all dosage forms and all packaging, Rx Only, Avella of Houston, Houston, TX 77054

by Advanced Pharma Inc.

Reason
Labeling: Not Elsewhere Classified: Products may contain synthetic latex and/or natural latex.
Published
May 31, 2017
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Estrone, For Prescription Compounding, packaged in a) 1 G bottle (NDC: 51552-0445-1), b) 5 G bottle (NDC 51552-0445-2), c) 25 G bottle (NDC: 51552-0445-4), d) 100 G bottle (NDC: 51552-0445-5), RX only, Distributed by Fagron, Inc. 2400 Pilot Knob Rd, St. Paul, MN 55120 Tel. 1-(800) 423-6967 Also packaged as: Estrone USP, For Prescription Compounding, packaged in a) 1 G bottle (NDC 52372-9494-01), b) 5 G bottle (NDC 52372-9494-05), c) 25 G bottle (NDC 52372-9494-03), d) 100 G bottle ( NDC 52372-9494-02), Rx only, Distributed by FREEDOM 801 W. New Orleans St. Broken Arrow, OK 74011 Tel. (877) 839-8547

by Fagron, Inc

Reason
cGMP Deviations: lack of quality assurance at the API manufacturer.
Published
May 31, 2017
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Estriol, For Prescription Compounding, packaged in a) 1 G bottle (NDC: 51552-1392-1), b) 5 G bottle (NDC: 51552-1392-2), c) 25 G bottle (NDC: 51552-1392-3), d) 100 G bottle (NDC: 51552-1392-5), RX only, Distributed by Fagron, Inc. 2400 Pilot Knob Rd, St. Paul, MN 55120 Tel. 1-(800) 423-6967 Also packaged as: Estriol USP Micronized, For prescription compounding, packaged in a 100 G bottle (NDC 52372-9292-01), Rx only, Distributed by FREEDOM, 801 W. New Orleans St. Broken Arrow, OK 74011

by Fagron, Inc

Reason
cGMP Deviations: lack of quality assurance at the API manufacturer.
Published
May 31, 2017
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Alprazolam Extended-release Tablets, USP, 1 mg, 60-count bottle, Rx Only, Manufactured and Distributed by: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 U.S.A., NDC 0378-5022-91

by Mylan Pharmaceuticals Inc.

Reason
Failed Dissolution Specifications
Published
May 31, 2017
Distribution
Nationwide

View recall →

FDA Recall United States Terminated Historical recordClass I

HVF Inc. d.b.a Huson Valley Farms

Product
Nutty INFUSIONS Ginger Wasabi Cashew Butter, NET WT. 10 OZ (…
Reason
Listeria monocytogenes contamination
Published
May 31, 2017
Distribution
Nationwide

View recall →

FDA Recall United States Terminated Historical recordClass I

HVF Inc. d.b.a Huson Valley Farms

Product
Nutty INFUSIONS Roasted Cashew Butter, NET WT. 10 OZ (284 g)
Reason
Listeria monocytogenes contamination
Published
May 31, 2017
Distribution
Nationwide

View recall →

FDA Recall United States Terminated Historical recordClass III

RB Manufacturing LLC

Product
Schiff Move Free Advanced Plus MSM & Vitamin D3 with Glucosa…
Reason
RB Manufacturing is recalling Move Free Advance Tablets due to incorrect packaging.
Published
May 31, 2017
Distribution
Nationwide

View recall →

FDA Recall United States Terminated Historical recordClass I

Lords Organics Llc

Product
Organic Veda brand Ginger Powder, 24 jars, Net Wt. 16 oz. (4…
Reason
Lord Organics is recalling ginger powder because it has the potential to be contaminated with Salmonella.
Published
May 31, 2017
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

Fluocinonide Cream UPS, 0.05% (Emulsified Base), packaged in 60 g tube, Rx only, Mfd. by: Taro Pharmaceuticals Inc., Brampton, Ontario, Canada, Dist. by Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY 10532, NDC 51672-1254-3

by Taro Pharmaceuticals U.S.A., Inc.

Reason
Cross contamination with other products: Certain lots of Fluocinonide Cream were found to be contaminated with a small quantity of hydrocortisone-17-valerate.
Published
May 24, 2017
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

VITAMIN D3 IN OLIVE OIL SDV 100,000U/ML INJ, Injection, 150,000u/mL, Rx only, packaged in 2mL Glass/Single Dose vial, Prepared by Key Compounding Pharmacy

by Key Pharmacy and Compounding Center

Reason
Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.
Published
May 24, 2017
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

VITAMIN D3 IN OLIVE OIL SDV 100,000U/ML INJ, Injection, 100,000u/mL, Rx only, packaged in 1 mL Glass/Single Dose vial, Prepared by Key Compounding Pharmacy

by Key Pharmacy and Compounding Center

Reason
Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.
Published
May 24, 2017
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

VITAMIN B COMPLEX 1ML SDV NA INJ, Injection, 100mg/2mg/2mg/2mg/100mg/mL, Rx only, 1mL Glass; Single Dose, Prepared by Key Compounding Pharmacy

by Key Pharmacy and Compounding Center

Reason
Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.
Published
May 24, 2017
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

TESTOST AQ MDV 50MG/ML INJ, Injection, 50mg/mL, Rx only, packaged in 5mL and 10mL Glass/Multiple Dose vial, Prepared by Key Compounding Pharmacy

by Key Pharmacy and Compounding Center

Reason
Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.
Published
May 24, 2017
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

TESTOST CYP SESAME OIL 5ML MDV 100MG/ML INJ, Injection, 100mg/mL, Rx only, 5 mL Glass/Multiple Dose vial, Prepared by Key Compounding Pharmacy

by Key Pharmacy and Compounding Center

Reason
Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.
Published
May 24, 2017
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

SOD PHENYLBUTYRATE SDV 30ML (CALIF or NEZ-CALIF) 200MG/ML INJ, Injection, 200mg/mL, Rx only, 30 mL Glass/Single Dose vial, Prepared by Key Compounding Pharmacy

by Key Pharmacy and Compounding Center

Reason
Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.
Published
May 24, 2017
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

SODIUM CHLORIDE INH PF GV 0.9% SOLN, Inhalation Solution, 0.90%, Rx only, 5mL Glass/Single Dose vial, Prepared by Key Compounding Pharmacy

by Key Pharmacy and Compounding Center

Reason
Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.
Published
May 24, 2017
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

SODIUM CARBOXYM-CELL PF 0.5% OPHTH, opthalmic, 0.50%, Rx only, 10mL Glass/Multiple Dose vial, Prepared by Key Compounding Pharmacy

by Key Pharmacy and Compounding Center

Reason
Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.
Published
May 24, 2017
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

SODIUM BICARB 50ML MDV 8.4% (2 MOSMOL/ML) INJ, Injection, 8.40%, Rx only, 5mL Glass/Multiple Dose via, Prepared by Key Compounding Pharmacy

by Key Pharmacy and Compounding Center

Reason
Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.
Published
May 24, 2017
Distribution
Nationwide

View recall →

Data last updated:

Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.